Trial Profile
Investigation of the reasons for withdrawal from long-term treatment with mirabegron of treatment-naive Japanese female patients with overactive bladder in the real-world clinical setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2019
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 12 Sep 2017 New trial record